STERIS announces new x-ray processing facility in kuala ketil, malaysia

May 16, 2022

  • Supports medical device manufacturing with additional capacity

  • Complements existing EO, E-beam, gamma, and testing services offered in Malaysia

As part of our long-term commitment to supporting medical device manufacturing, STERIS is pleased to announce plans for the construction of a new X-ray processing facility in Kuala Ketil, Malaysia.

The expansion of services in Malaysia furthers our commitment of ensuring patient safety through a technology-neutral service offering that includes radiation and gas processing options, now and well into the future. In addition to the new X-ray facility in Kuala Ketil, we support medical device manufacturing in Malaysia through our existing ethylene oxide, electron beam, gamma, and microbiological testing services in Kulim, Port Klang, and Rawang. We also recently announced the addition of ethylene oxide processing through a new site being constructed in Batu Kawan, Malaysia.

Increased demand in medical device manufacturing has accelerated our plans for global expansion. The continued expansion of processing options throughout our global network allows us to support Customers with both routine services and processing redundancy

twitter-logo

About STERIS

STERIS is a leading global provider of products and services that support patient care with an emphasis on infection prevention. WE HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life sciences products and services. For more information, visit www.steris.com.

 
Related Posts
Exterior View of STERIS Facility in Batu Kawan, Malaysia
May 1, 2025

As part of our long-term commitment to supporting global medical device manufacturing, STERIS is pleased to announce a new ethylene oxide (EO) processing facility in Batu Kawan industrial Park in Penang, Malaysia.

202310-LibertyvilleIL-Lab-5
March 28, 2025
March 28, 2025 – As part of our long-term commitment to supporting medical device and pharmaceutical manufacturing, STERIS Applied Sterilization Technologies (AST) is pleased to announce the addition of Extractables and Leachables (E&L) testing, featuring advanced chemical analysis.
New-Swindon-Lab-1-600x600
February 5, 2025
February 5, 2025 – As part of our long-term commitment to supporting medical device and pharmaceutical manufacturing, STERIS is pleased to announce our South Marston, UK laboratory has relocated to Swindon, UK. The new laboratory supports the increased demand in volume and complexity of medical devices and pharmaceuticals in the region.
STERIS is pleased to announce our brooklyn park mn usa laboratory now offers bacteria
January 10, 2025
January 10, 2025 – As part of our long-term commitment to supporting global healthcare product manufacturing, STERIS is pleased to announce our Brooklyn Park, Minnesota, USA laboratory now offers a sustainable approach to bacterial endotoxin testing through the use of recombinant cascade reagents.